CoChat

CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSS

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

A 2-year randomised pilot study was conducted in 70 patients to see whether the osteoclast-inhibiting effect of calcitonin would reduce postmenopausal vertebral bone loss. An oestradiol-treated group was included in the study as a positive control since oestrogens are known to be effective. Calcitonin reduced vertebral bone loss in doses above 250 micrograms human calcitonin (50 international units) a week, and at this dose was as effective as oestradiol.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(88)91712-6

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 31 · Cited by 204

Research works printed but not linked: 4

  1. Sheetz, 1987, Bone related cells in culture express putative estrogen receptor mRNA and 125I-17-estradiol binding, J Bone Min Res, 2, 237
  2. Eriksen, 1987, Evidence of estrogen receptors in human bone cells, J Bone Min Res, 2, 238
  3. Gennari, 1985, Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis, Curr Ther Res, 38, 455
  4. Wallach, 1977, Effect of salmon calcitonin on skeletal mass in osteoporosis, Curr Ther Res Clin Exp, 22, 556

Metadata

Authors
Macintyre, I., Whitehead, M. I., Banks, L. M., Stevenson, J. C., Wimalawansa, S. J., & Healy, M. J. R.
Affiliations
  • King's College London (GB)
  • London School of Hygiene & Tropical Medicine (GB)
Venue
The Lancet
Publisher
Elsevier BV
Published
1988-04
Volume
331
Issue
8591
Pages
900-902
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W1988493901
Cited by
204
References
31
Citations by year
2024: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2013: 1
FWCI
27.08
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
calcitonin, postmenopausal bone loss, vertebral bone loss, osteoclast inhibition, estradiol, menopause, bone loss prevention, hormone replacement therapy
MeSH terms
Administration, Oral, Adult, Calcitonin, Clinical Trials as Topic, Estradiol, Female, Follow-Up Studies, Humans, Injections, Subcutaneous, Middle Aged, Osteoporosis, Patient Compliance, Pilot Projects, Progesterone, Radiography, Random Allocation, Self Administration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSS. https://app.cochat.ai/papers/10.1016/s0140-6736(88)91712-6
The paper
Macintyre, I., Whitehead, M. I., Banks, L. M., Stevenson, J. C., Wimalawansa, S. J., & Healy, M. J. R. (1988). CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSS. The Lancet. https://doi.org/10.1016/s0140-6736(88)91712-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.